TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF ELI LILLY AND COMPANY)

Lobbying client. Federal LDA filings.

Connected on the graph

Inbound (9)

date	from	type	amount	role	source
—	Jonathon Jones	lobbied_for	—		lda_lobbyist_client
—	John Michael Gonzalez	lobbied_for	—		lda_lobbyist_client
—	James Bryant Hall Ii	lobbied_for	—		lda_lobbyist_client
—	Emily Kirlin	lobbied_for	—		lda_lobbyist_client
—	Timothy A Molino	lobbied_for	—		lda_lobbyist_client
—	Corey Malmgren	lobbied_for	—		lda_lobbyist_client
2026-01-01	TIBER CREEK GROUP	lobbies_for	$80,000		lda_filing
2026-01-01	B HALL STRATEGIES, LLC	lobbies_for	$30,000		lda_filing
2026-01-01	Yakym, Rudy	co_acted_on_bill_with	—	hr6509-119	lda_filing

Outbound (3)

date	type	to	amount	role	source
2026-01-01	lobbies_on_bill	HR 6509 — SAFE Drugs Act of 2025	—	H.R. 6509	lobbying_bill_mention
2026-01-01	lobbies_on_bill	S 1041 — Affordable Prescriptions for Patients Act	—	S. 1041	lobbying_bill_mention
2026-01-01	lobbies_on_bill	S 1096 — Preserve Access to Affordable Generics and Biosimilars Act	—	S. 1096	lobbying_bill_mention

Source id: 127294
General description: Pharmaceutical company.
State: DC
Country: US
Principal place of business: US
Government-entity client: false
Effective date: 2020-01-01
Total spend (across 1 ingested filings): $80,000

Filings

Posted	Type	Year	Lobbying firm	Income
2026-04-18	`Q1`	2026	TIBER CREEK GROUP	$80,000

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page. Want to partner? Contact us.